Altor BioScience Corporation Email Format

BiotechnologyFlorida, United States51-200 Employees

Altor BioScience Corporation is a Miramar, Florida-based biotechnology company focused on cancer immunotherapy. It is developing therapies around three technology platforms: a T cell receptor–based approach that targets intracellular antigens such as p53, tissue factor antagonists, and IL-15–based immunotherapies. The company collaborates with external partners to advance these therapies and pursues co-development and commercialization opportunities. Several programs have progressed into human testing, including a p53-targeted TCR/IL-2 fusion that has reached phase II data for melanoma and bladder cancer, an anti-tissue factor antibody with phase II for ALI/ARDS and phase I for solid tumors, and an IL-15–based superagonist in clinical trials.

The company positions itself as a development partner within the biotechnology industry, enabling collaborations with larger pharma and biotech entities to advance oncology programs. Recent partnerships illustrate its approach, including a 2021 co-development agreement with GT Biopharma for a TriKE fusion protein.

Get verified Altor BioScience Corporation emails free

Company overview Employee directory